| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 28 May 2025 | 19 May 2025 |
| 3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter /financial year ended March 31 2025 and to discuss the matter of recommendation of dividend if any for the financial year ended March 31 2025 Outcome of Board Meeting dt 28-05-2025 (As Per BSE Announcement dated on 28.05.2025) Audited Standalone and Consolidated Financial Results for the quarter and year ended 31-03-2025 (As Per BSE Announcement Dated on :14.06.2025) | ||
| Board Meeting | 13 Feb 2025 | 3 Feb 2025 |
| 3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended on 31st December 2024. Submission of Unaudited Standalone and Consolidated Financial Results for the quarter and nine-months ended 31-12-2024 (As per BSE Announcement Dated on 13/02/2025) | ||
| Board Meeting | 13 Nov 2024 | 4 Nov 2024 |
| 3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company. The Board of Directors have considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on 30th September 2024 (As Per BSE Announcement Dated on: 13/11/2024) | ||
| Board Meeting | 12 Aug 2024 | 30 Jul 2024 |
| 3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results of the company for the first quarter ended on 30th June2024. Unaudited Standalone and Consolidated Financial Results for quarter ended 30-06-24 (As Per BSE Announcement Dated on: 12/08/2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.